Who Paid My Doc
Zemplar
Drug General Medicine
NDC 0074-1658-05
General payments
$1,400
Research payments
$689,872
Through program year 2025, $1,400 in general payments and $689,872 in research payments were reported against Zemplar (General Medicine).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $158,327 | 40 |
| 2024 | General | $1,400 | 4 |
| 2024 | Research | $154,928 | 33 |
| 2023 | Research | $90,927 | 33 |
| 2022 | Research | $118,015 | 18 |
| 2021 | Research | $104,152 | 8 |
| 2020 | Research | $63,523 | 3 |
Breakdown
Each share is of general payments naming this product in 2024.
Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2024 where a state was reported.
Records
4 general · 135 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.